These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4380004)

  • 1. In vivo inhibition of 3H-noradrenaline uptake by mouse brain slices in vitro.
    Ross SB; Renyi AL
    J Pharm Pharmacol; 1966 May; 18(5):322-3. PubMed ID: 4380004
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices.
    Pelayo F; Dubocovich ML; Langer SZ
    Eur J Pharmacol; 1980 Jun; 64(2-3):143-55. PubMed ID: 6249614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.
    Ross SB; Renyi AL
    Eur J Pharmacol; 1969 Sep; 7(3):270-7. PubMed ID: 5351984
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulated formation of adenosine 3',5'-monophosphate by desipramine in brain slices.
    Kodama T; Matsukado Y; Suzuki T; Tanaka S; Shimizu H
    Biochim Biophys Acta; 1971 Oct; 252(1):165-70. PubMed ID: 4334914
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of amitriptyline, desipramine and imipramine on the vivo brain synthesis of 3H-noradrenaline from 3H-L-dopa in the rat.
    Nielsen M; Eplov L; Scheel-Krüger J
    Psychopharmacologia; 1975; 41(3):249-54. PubMed ID: 1098088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of 3H-noradrenaline (3H-NA) in plasma from patients treated with thymoleptic or neuroleptic drugs.
    Tuck D; Hamberger B; Sjöqvist F
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):87. PubMed ID: 5314453
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W; Pugsley TA
    Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices.
    el-Mas M; Hughes IE
    Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
    Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
    Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
    [No Abstract]   [Full Text] [Related]  

  • 11. Permeability changes in the blood-brain barrier induced by nortriptyline and chlorpromazine.
    Pardridge WM; Crawford IL; Connor JD
    Toxicol Appl Pharmacol; 1973 Sep; 26(1):49-57. PubMed ID: 4748138
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.
    Ng KY; Chase TN; Kopin IJ
    Nature; 1970 Oct; 228(5270):468-9. PubMed ID: 5482502
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by drugs of the accumulation in vitro of 5-hydroxytryptamine in guinea-pig vas deferens.
    Eccleston D; Thoa NB; Axelrod J
    Nature; 1968 Mar; 217(5131):846-7. PubMed ID: 5641144
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex.
    Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):364-7. PubMed ID: 4152863
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain.
    Schubert J; Nybäck H; Sedvall G
    J Pharm Pharmacol; 1970 Feb; 22(2):136-9. PubMed ID: 4392252
    [No Abstract]   [Full Text] [Related]  

  • 16. Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):382-94. PubMed ID: 1173528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
    Koe BK; Constantine JW
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):71-80. PubMed ID: 5010834
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake of (3H)5-hydroxytryptamine and (3H)noradrenaline by slices of rat brain incubated in plasma from patients treated with chlorimipramine, imipramine or amitroptyline.
    Tuck JR; Punell G
    J Pharm Pharmacol; 1973 Jul; 25(7):573-4. PubMed ID: 4147057
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation of alpha-methyltyramine by the noradrenaline uptake process in the isolated rat heart.
    Iversen LL
    J Pharm Pharmacol; 1966 Aug; 18(8):481-4. PubMed ID: 4381852
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the influence of some psychotropic substances on the grooming behaviour of white mice.
    Rohte O
    Br J Pharmacol; 1968 Sep; 34(1):236P-238P. PubMed ID: 5676037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.